טוען...
Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?
According to the current guidelines, severe asthma still represents a controversial topic in terms of definition and management. The introduction of novel biological therapies as a treatment option for severe asthmatic patients paved the way to a personalized approach, which aims at matching the app...
שמור ב:
| הוצא לאור ב: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6016214/ https://ncbi.nlm.nih.gov/pubmed/29992143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4617565 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|